دورية أكاديمية
أعرض في EDS

Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates.

التفاصيل البيبلوغرافية
العنوان: Cost impact of procalcitonin-guided decision making on duration of antibiotic therapy for suspected early-onset sepsis in neonates.
المؤلفون: Geraerds AJLM; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. a.geraerds@erasmusmc.nl., van Herk W; Division of Paediatric Infectious Diseases & Immunology, Department of Paediatrics, Erasmus MC University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands., Stocker M; Department of Paediatrics, Neonatal and Paediatric Intensive Care Unit, Children's Hospital Lucerne, Lucerne, Switzerland., El Helou S; Division of Neonatology, McMaster University Children's Hospital, Hamilton Health Sciences, Hamilton, ON, Canada., Dutta S; Division of Neonatology, McMaster University Children's Hospital, Hamilton Health Sciences, Hamilton, ON, Canada., Fontana MS; Department of Paediatrics, Neonatal and Paediatric Intensive Care Unit, Children's Hospital Lucerne, Lucerne, Switzerland., Schuerman FABA; Neonatal Intensive Care Unit, Isala Women and Children's Centre, Isala Hospital, Zwolle, The Netherlands., van den Tooren-de Groot RK; Department of Paediatrics, Haaglanden Medical Center, 's Gravenhage, The Netherlands., Wieringa J; Department of Paediatrics, Haaglanden Medical Center, 's Gravenhage, The Netherlands., Janota J; Neonatal Unit, Department of Obstetrics and Gynaecology, Motol University Hospital, Second Medical Faculty, Charles University, Prague, Czech Republic.; Institute of Pathological Physiology, First Medical Faculty, Charles University, Prague, Czech Republic., van der Meer-Kappelle LH; Department of Neonatology, Reinier de Graaf Gasthuis, Delft, The Netherlands., Moonen R; Department of Neonatology, Zuyderland Medical Centre, Heerlen, The Netherlands., Sie SD; Department of Neonatology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Vries E; Department of Paediatrics, Jeroen Bosch Hospital, 's-Hertogenbosch, The Netherlands., Donker AE; Department of Paediatrics, Maxima Medical Centre, Veldhoven, The Netherlands., Zimmerman U; Department of Paediatrics, Kantonsspital Winterthur, Winterthur, Switzerland., Schlapbach LJ; Department of Paediatrics, Bern University Hospital, Inselspital, University of Bern, Bern, Switzerland.; Paediatric Critical Care Research Group, Mater Research Institute, University of Queensland, Brisbane, QLD, Australia.; Paediatric Intensive Care Unit, Lady Cilento Children's Hospital, Brisbane, QLD, Australia., de Mol AC; Department of Neonatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Hoffman-Haringsma A; Department of Neonatology, Sint Franciscus Gasthuis, Rotterdam, The Netherlands., Roy M; Department of Neonatology, St. Josephs Healthcare, Hamilton Health Sciences, Hamilton, ON, Canada., Tomaske M; Department of Paediatrics, Stadtspital Triemli, Zürich, Switzerland., Kornelisse RF; Division of Neonatology, Erasmus MC University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands., van Gijsel J; Julius Training General Practitioner, University Medical Centre Utrecht, Utrecht, The Netherlands., Visser EG; Division of Paediatric Infectious Diseases & Immunology, Department of Paediatrics, Erasmus MC University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands., van Rossum AMC; Division of Paediatric Infectious Diseases & Immunology, Department of Paediatrics, Erasmus MC University Medical Centre - Sophia Children's Hospital, Rotterdam, The Netherlands., Polinder S; Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.
المصدر: Critical care (London, England) [Crit Care] 2021 Oct 20; Vol. 25 (1), pp. 367. Date of Electronic Publication: 2021 Oct 20.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE
أسماء مطبوعة: Publication: London, UK : BioMed Central Ltd
Original Publication: London : Current Science Ltd, c1997-
مواضيع طبية MeSH: Anti-Bacterial Agents*/therapeutic use , Clinical Decision-Making*/methods , Duration of Therapy* , Health Care Costs*/statistics & numerical data , Sepsis*/diagnosis , Sepsis*/drug therapy, Early Diagnosis ; Humans ; Infant, Newborn ; Procalcitonin/blood
مستخلص: Backgrounds: The large, international, randomized controlled NeoPInS trial showed that procalcitonin (PCT)-guided decision making was superior to standard care in reducing the duration of antibiotic therapy and hospitalization in neonates suspected of early-onset sepsis (EOS), without increased adverse events. This study aimed to perform a cost-minimization study of the NeoPInS trial, comparing health care costs of standard care and PCT-guided decision making based on the NeoPInS algorithm, and to analyze subgroups based on country, risk category and gestational age.
Methods: Data from the NeoPInS trial in neonates born after 34 weeks of gestational age with suspected EOS in the first 72 h of life requiring antibiotic therapy were used. We performed a cost-minimization study of health care costs, comparing standard care to PCT-guided decision making.
Results: In total, 1489 neonates were included in the study, of which 754 were treated according to PCT-guided decision making and 735 received standard care. Mean health care costs of PCT-guided decision making were not significantly different from costs of standard care (€3649 vs. €3616). Considering subgroups, we found a significant reduction in health care costs of PCT-guided decision making for risk category 'infection unlikely' and for gestational age ≥ 37 weeks in the Netherlands, Switzerland and the Czech Republic, and for gestational age < 37 weeks in the Czech Republic.
Conclusions: Health care costs of PCT-guided decision making of term and late-preterm neonates with suspected EOS are not significantly different from costs of standard care. Significant cost reduction was found for risk category 'infection unlikely,' and is affected by both the price of PCT-testing and (prolonged) hospitalization due to SAEs.
(© 2021. The Author(s).)
References: Arch Dis Child Fetal Neonatal Ed. 2011 Jan;96(1):F9-F14. (PMID: 20876594)
Crit Care. 2018 Nov 13;22(1):293. (PMID: 30424796)
PLoS One. 2013 Aug 06;8(8):e68419. (PMID: 23936304)
Langenbecks Arch Surg. 2009 Mar;394(2):221-6. (PMID: 19034493)
Intensive Care Med. 2011 May;37(5):747-62. (PMID: 21380522)
Pediatr Infect Dis J. 2016 May;35(5):494-500. (PMID: 26766143)
Mymensingh Med J. 2006 Jan;15(1):108-14. (PMID: 16467776)
Chest. 2017 Jan;151(1):23-33. (PMID: 27568580)
Lancet Infect Dis. 2004 Oct;4(10):620-30. (PMID: 15451490)
Arch Dis Child Fetal Neonatal Ed. 2020 Mar;105(2):201-208. (PMID: 31296695)
OMICS. 2019 Oct;23(10):508-515. (PMID: 31509068)
Lancet. 1993 Feb 27;341(8844):515-8. (PMID: 8094770)
Lancet. 2017 Aug 26;390(10097):871-881. (PMID: 28711318)
Respir Med. 2011 Dec;105(12):1939-45. (PMID: 21959024)
BMC Pediatr. 2010 Dec 08;10:89. (PMID: 21143869)
PLoS One. 2019 Apr 23;14(4):e0214222. (PMID: 31013271)
فهرسة مساهمة: Keywords: Costs; Neonates; Procalcitonin-guided decision making; Sepsis
المشرفين على المادة: 0 (Anti-Bacterial Agents)
0 (Procalcitonin)
تواريخ الأحداث: Date Created: 20211021 Date Completed: 20211230 Latest Revision: 20211230
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC8529813
DOI: 10.1186/s13054-021-03789-x
PMID: 34670582
قاعدة البيانات: MEDLINE
الوصف
تدمد:1466-609X
DOI:10.1186/s13054-021-03789-x